Lantheus Holdings, Inc. Gain (Loss) on Extinguishment of Debt
Lantheus Holdings, Inc. (LNTH) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-02-26
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was -$588.00K.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was $0.00.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was -$588.00K, a 166.14% decline from fiscal 2021.
- Lantheus Holdings, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $889.00K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt as first filed | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 | |||||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | |||||||
| 2022-12-31 | -$588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$588.00K derived: sum of 2 quarters · filed 2025-02-26 | -$588.00K derived: sum of 3 quarters · filed 2025-02-26 | -$588.00K 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2022-04-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $889.00K 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $889.00K 10-Q · filed 2022-11-03 | $889.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $889.00K 10-Q · filed 2022-08-04 | $889.00K derived: sum of 3 quarters · filed 2023-02-23 | $889.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $889.00K 10-Q · filed 2022-04-29 | $889.00K derived: sum of 2 quarters · filed 2023-02-23 | $889.00K derived: sum of 3 quarters · filed 2023-02-23 | $889.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $0.00 10-Q · filed 2021-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | -$3.20M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | -$3.20M derived: sum of 3 quarters · filed 2022-02-24 | -$3.20M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 | -$3.20M derived: sum of 2 quarters · filed 2019-10-31 | -$3.20M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$3.20M 10-K · filed 2022-02-24 | -$3.20M 10-Q · filed 2019-07-25 | -$3.20M 10-Q · filed 2020-07-31 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | -$281.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-25 | $0.00 10-Q · filed 2019-07-25 | -$281.00K derived: sum of 3 quarters · filed 2020-02-25 | -$281.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 | -$281.00K derived: sum of 2 quarters · filed 2020-02-25 | -$281.00K derived: sum of 3 quarters · filed 2020-02-25 | -$281.00K derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$281.00K derived: sum of 2 quarters · filed 2020-02-25 | -$281.00K derived: sum of 3 quarters · filed 2020-02-25 | -$2.44M 10-K · filed 2020-02-25 | ||||
| 2017-12-29 | $200.00K 10-K · filed 2018-02-26 | |||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | -$2.16M 10-Q · filed 2018-10-30 | -$2.64M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$2.16M 10-Q · filed 2018-08-01 | -$2.64M derived: sum of 3 quarters · filed 2019-02-20 | |||||
| 2017-03-31 | -$2.16M 10-Q · filed 2018-05-02 | -$2.64M derived: sum of 2 quarters · filed 2019-02-20 | ||||||
| 2017-03-30 | $2.20M 10-K · filed 2019-02-20 | -$2.20M 10-Q · filed 2017-08-01 | ||||||
| 2016-12-31 | -$481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$1.90M 10-K · filed 2019-02-20 | $0.00 10-K · filed 2017-02-23 | |||||
| 2016-09-30 | -$1.42M 10-Q · filed 2017-11-02 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-02 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | -$15.53M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | -$15.53M derived: sum of 3 quarters · filed 2018-02-26 | -$15.53M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$15.53M derived: sum of 2 quarters · filed 2016-11-01 | -$15.53M 10-Q · filed 2016-11-01 | |||||
| 2015-06-30 | -$15.53M 10-Q · filed 2016-08-04 | -$15.53M 10-Q · filed 2016-08-04 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |